Elevating aged mouse tail tendon glucosepane to human-equivalent levels via ex vivo D-ribose glycation and then treat...

IF Revel Pharmaceuticals' designer glucosepane-cleaving enzyme (lead biocatalyst, dose titrated to achieve ≥50% glucosepane reduction as confirmed by LC-MS/MS, administered via ex vivo bath incubation at physiological pH 7.4, 37°C) is applied to isolated tail tendon fascicles from aged (24-month-old) male C57BL/6J mice whose glucosepane load has been elevated to human-equivalent concentrations (~2,000–5,000 pmol/mg collagen) through a standardized 72-hour ex vivo D-ribose incubation protocol prior to treatment,

THEN a statistically significant reduction in tensile Young's modulus (≥20% vs. vehicle-treated aged controls), a restoration of stress-relaxation time constants toward values observed in young (3-month-old) reference tendons, and a corresponding reduction in glucosepane content quantified by LC-MS/MS will be observed,

BECAUSE:

1. Glucosepane forms irreversible covalent crosslinks between lysine and arginine residues on adjacent collagen triple helices, functioning as rigid molecular tethers that restrict interfibrillar sliding — the primary mechanism of viscoelastic energy dissipation in tendon (as described in the literature review, citing Monnier et al., Gerontology, 2012, and the Acta Biomaterialia, 2014 review on collagen crosslinks and aging).
2. Murine tail tendons do not accumulate glucosepane at human-equivalent concentrations within the mouse lifespan; a D-ribose ex vivo glycation step overcomes this translational gap by artificially elevating glucosepane to physiologically relevant human concentrations, creating a chemically faithful substrate for enzymatic testing [SPECULATIVE — supported by the literature review's explicit identification of this as a critical gap requiring induced glycation to mimic human aging profiles].
3. The Spiegel Lab's total synthesis of glucosepane (Draghici et al., Science, 2015, as cited in the literature review) enabled identification of lead glucosepane-cleaving enzymes, likely sourced from soil bacteria or fungi with specialized catabolic machinery for glycated organic matter, which are designed to hydrolyze the imidazopyridinium core of the glucosepane crosslink, severing the covalent tether between collagen triple helices (literature review).
4. Enzymatic hydrolysis of glucosepane crosslinks would restore degrees of freedom for interfibrillar sliding within the collagen fibril network, directly reducing apparent stiffness (Young's modulus) and improving the capacity for viscoelastic energy dissipation (stress-relaxation), because these macroscopic mechanical properties are downstream of molecular-level interfibrillar mobility (literature review, Acta Biomaterialia, 2014).
5. Because ALT-711/alagebrium failed against glucosepane despite cleaving less-stable AGE crosslinks and demonstrating functional stiffness reduction in rodent models (Vasan et al., Nature, 1996, as cited in the literature review), successful glucosepane-specific enzymatic cleavage with functional biomechanical resc...

SENS category: GlycoSENS